Testicular cancer · 6 regimens
Cost vs Efficacy · 1 point
| Regimen | Biomarker | Cost/cycle ↓ | Cycle | PFS ↕ | OS ↕ | Est. cycles | Course cost ↕ | Evidence |
|---|---|---|---|---|---|---|---|---|
VAB-6 Variant #01 Partial | — | R 11 816 | 28d | — | — | ~2 | ~R 23 633 indirect | — |
BEP Variant #01 Partial | — | R 2 787 | 21d | — | — | ~3 | ~R 8 361 indirect | — |
BVP Variant #01 Partial | — | R 2 180 | 28d | — | — | ~4 | ~R 8 718 indirect | — |
Carboplatin monotherapy Variant #01 | — | R 535 | 21d | ~5.8 mo | ~21.0 mo | ~2 | ~R 1 070 PFS proxy · indirect | 7 |
Observation Partial | — | — | — | — | — | — | — | 2 |
Radiation therapy N/A - radiation | — | — | 49d | — | — | — | — | 3 |
6 of 6 regimens shown